Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial
Cancer · 2024
DOI: 10.1002/cncr.35300 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cancer, 2024. Verfasst von Christina Sauer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Neoplasms, Quality of Life, Immunotherapy, Mobile Applications. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Center for Tumor Diseases Heidelberg.
Abstract (Originalsprache)
Background
For patients receiving immune checkpoint inhibitors, early detection of immune‐related adverse events (irAEs) is critical for one’s safety. To this end, a smartphone app (SOFIA) was developed that featured the assessment of electronic patient‐reported outcomes (ePROs) focusing on irAEs as well as a set of comprehensive supportive information. Its feasibility and preliminary efficacy were evaluated in a randomized controlled trial (RCT).
Methods
Patients who received immune checkpoint inhibition therapy were randomly assigned to an intervention group (IG) or a control group (CG; care as usual). During the 12‐week intervention period, IG patients used SOFIA to report twice weekly ePROs and receive cancer‐ and immunotherapy‐relevant contents. Before a patient’s next clinical visit, the physician in charge was given the ePRO reports. The primary objective was to test the feasibility of SOFIA. Furthermore, the preliminary efficacy of SOFIA for health‐related quality of life (HRQOL), psychosocial outcomes, and medical data was examined. Clinical outcomes were assessed at baseline (T0), post‐intervention (T1), and a 3‐month follow‐up (T2).
Results
Seventy‐one patients were randomized to the IG ( n = 34) or the CG ( n = 37). SOFIA showed high feasibility and acceptance. At T1, patients in the IG reported significantly better HRQOL and role functioning and less depression, distress, and appetite loss. No significant differences were revealed regarding medical data, the utilization of supportive care services, or survival.
Conclusions
SOFIA showed high feasibility and acceptance and improved HRQOL and psychosocial outcomes. These results suggest further evaluation of efficacy in a large‐scale confirmatory multicenter RCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Heidelberg, Germany.
- National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
- Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
- Vanudis GmbH, Heidelberg, Germany.
- Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- German Cancer Consortium (DKTK), Heidelberg, Germany.
ORCID-Profile: Christina Sauer
Förderung
- National Center for Tumor Diseases Heidelberg
Zitieren
APA
Sauer, C., Zschäbitz, S., Krauss, J., Walle, T., Haag, G. M., Jäger, D., Hiller, K., Bugaj, T. J., Friederich, H. C., & Maatouk, I. (2024). Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial. Cancer. https://doi.org/10.1002/cncr.35300
Vancouver
Sauer C, Zschäbitz S, Krauss J, Walle T, Haag GM, Jäger D, et al. Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial. Cancer. 2024. doi:10.1002/cncr.35300
BibTeX
@article{Sauer2024,
author = {Sauer, Christina and Zschäbitz, Stefanie and Krauss, Jürgen and Walle, Thomas and Haag, Georg Martin and Jäger, Dirk and Hiller, Kiriaki and Bugaj, Till Johannes and Friederich, Hans-Christoph and Maatouk, Imad},
title = {Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35300}
}
EUVIMED